NO991175D0 - Anvendelse av proteiner som midler mot autoimmune sykdommer - Google Patents

Anvendelse av proteiner som midler mot autoimmune sykdommer

Info

Publication number
NO991175D0
NO991175D0 NO991175A NO991175A NO991175D0 NO 991175 D0 NO991175 D0 NO 991175D0 NO 991175 A NO991175 A NO 991175A NO 991175 A NO991175 A NO 991175A NO 991175 D0 NO991175 D0 NO 991175D0
Authority
NO
Norway
Prior art keywords
proteins
agents
autoimmune diseases
autoimmune
diseases
Prior art date
Application number
NO991175A
Other languages
English (en)
Norwegian (no)
Other versions
NO991175L (no
Inventor
Alberto E Panerai
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI961922 external-priority patent/IT1284556B1/it
Priority claimed from ITMI961919 external-priority patent/IT1284553B1/it
Priority claimed from ITMI961921 external-priority patent/IT1284555B1/it
Priority claimed from ITMI961920 external-priority patent/IT1284554B1/it
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO991175D0 publication Critical patent/NO991175D0/no
Publication of NO991175L publication Critical patent/NO991175L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/846—Liver

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991175A 1996-09-18 1999-03-10 Anvendelse av proteiner som midler mot autoimmune sykdommer NO991175L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI961922 IT1284556B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti contro la sclerosi multipla
ITMI961919 IT1284553B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiartritici
ITMI961921 IT1284555B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antidiabetici
ITMI961920 IT1284554B1 (it) 1996-09-18 1996-09-18 Uso di proteine come agenti antiaterosclerotici
PCT/EP1997/005079 WO1998011909A1 (en) 1996-09-18 1997-09-17 Use of proteins as agents against autoimmune diseases

Publications (2)

Publication Number Publication Date
NO991175D0 true NO991175D0 (no) 1999-03-10
NO991175L NO991175L (no) 1999-03-10

Family

ID=27453037

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991175A NO991175L (no) 1996-09-18 1999-03-10 Anvendelse av proteiner som midler mot autoimmune sykdommer

Country Status (22)

Country Link
US (2) US6468536B1 (zh)
EP (1) EP0928197B1 (zh)
JP (1) JP2001501925A (zh)
KR (1) KR20000036207A (zh)
CN (1) CN1151838C (zh)
AR (1) AR009952A1 (zh)
AT (1) ATE233569T1 (zh)
AU (1) AU723669B2 (zh)
BR (1) BR9711499A (zh)
CA (1) CA2266346A1 (zh)
CZ (1) CZ293926B6 (zh)
DE (1) DE69719525T2 (zh)
DK (1) DK0928197T3 (zh)
ES (1) ES2192669T3 (zh)
IL (1) IL129024A0 (zh)
NO (1) NO991175L (zh)
NZ (1) NZ334714A (zh)
PL (1) PL188746B1 (zh)
PT (1) PT928197E (zh)
RU (1) RU2196606C2 (zh)
TR (1) TR199900596T2 (zh)
WO (1) WO1998011909A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (ja) 1997-02-27 2004-04-19 日本たばこ産業株式会社 細胞間接着及びシグナル伝達を媒介する細胞表面分子
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
IT1290828B1 (it) 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
JP3871503B2 (ja) 1999-08-30 2007-01-24 日本たばこ産業株式会社 免疫性疾患治療剤
JP4210454B2 (ja) 2001-03-27 2009-01-21 日本たばこ産業株式会社 炎症性腸疾患治療剤
JP3597140B2 (ja) 2000-05-18 2004-12-02 日本たばこ産業株式会社 副刺激伝達分子ａｉｌｉｍに対するヒトモノクローナル抗体及びその医薬用途
MXPA02012091A (es) 2000-06-08 2004-08-19 Rakepoll Holding B V Un metodo de tratamiento de esclerosis lateral amiotrofica con una proteina que se puede extraer de organos de mamifero.
JP4212278B2 (ja) 2001-03-01 2009-01-21 日本たばこ産業株式会社 移植片拒絶反応抑制剤
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20010761A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 per il trattamento e la prevenzione dell'epatite cronica attiva
KR20060114011A (ko) * 2004-01-16 2006-11-03 씨바이오 리미티드 Ｔｏｌｌ-유사 수용체 유도성 사이토킨 및 케모킨 분비의샤페로닌 10 조절

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024247A (en) * 1971-12-27 1977-05-17 Palolab Pharmaceuticals Corporation Composition and method of using a protein mixture derived from liver
IT1244879B (it) 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.
FR2688227A1 (fr) 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale

Also Published As

Publication number Publication date
ATE233569T1 (de) 2003-03-15
CN1230892A (zh) 1999-10-06
PL332282A1 (en) 1999-08-30
NO991175L (no) 1999-03-10
AU4774797A (en) 1998-04-14
EP0928197B1 (en) 2003-03-05
RU2196606C2 (ru) 2003-01-20
AU723669B2 (en) 2000-08-31
TR199900596T2 (xx) 1999-06-21
DE69719525D1 (de) 2003-04-10
PL188746B1 (pl) 2005-04-29
PT928197E (pt) 2003-06-30
BR9711499A (pt) 1999-08-24
IL129024A0 (en) 2000-02-17
KR20000036207A (ko) 2000-06-26
JP2001501925A (ja) 2001-02-13
AR009952A1 (es) 2000-05-17
WO1998011909A1 (en) 1998-03-26
CN1151838C (zh) 2004-06-02
CA2266346A1 (en) 1998-03-26
ES2192669T3 (es) 2003-10-16
EP0928197A1 (en) 1999-07-14
CZ91599A3 (cs) 1999-08-11
US6468536B1 (en) 2002-10-22
CZ293926B6 (cs) 2004-08-18
DK0928197T3 (da) 2003-06-23
US20030108558A1 (en) 2003-06-12
NZ334714A (en) 2000-08-25
DE69719525T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
NO992806D0 (no) Terapeutiske midler
NO995712D0 (no) Oftalmiske preparater
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
NO991175D0 (no) Anvendelse av proteiner som midler mot autoimmune sykdommer
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ID21424A (id) Konfigurasi katup gabungan untuk unit siklus-uap
NO985571D0 (no) Legemiddel for autoimmunsykdommer
NO980058D0 (no) Opthalmiske preparater
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO991174D0 (no) Anvendelse av proteiner som anti-retrovirale midler
DE69523817D1 (de) Desodorisierende Präparate
FI954857A0 (fi) Olefiinien runkoisomerointi
HUP9904268A3 (en) Use of proteins as agents against autoimmune diseases
SI0928197T1 (en) Use of proteins as agents against autoimmune diseases
KR960011685U (ko) 조명등 결합구조
ZA978363B (en) Use of proteins as agents against autoimmune diseases.
KR970006906U (ko) 씨디-롬 드라이브의 듀얼 인터페이스 혼용장치
KR970024153U (ko) 시동모우터의 작동레버
SE9703137D0 (sv) Novel treatment of autoimmune diseases
KR980001951U (ko) 승합 차량의 정차스위치
KR970032065U (ko) 자동차의 풋레스트
UA25773A (uk) Відбивач компактhого полігоhа

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application